Orphan designation: povetacicept Treatment of primary membranous nephropathy, 23/02/2026 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 13 April 2026 - 9:49

Orphan designation: povetacicept Treatment of primary membranous nephropathy, 23/02/2026 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-26-3205-0

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters